Discover how changes in blood lipids serve as powerful predictors of liver damage in chronic hepatitis B patients, offering new diagnostic and prognostic tools.
Exploring the delicate balance between viral control and freedom from medication for chronic hepatitis B patients when antiviral therapy is discontinued.